Barbital

Barbital

SCHEMBL1650226

CCC1(CC)C(=O)NC(=O)NC1=O.Nc1nc(Nc2ccc(Br)cc2)nc(Nc2ccc(Br)cc2)n1

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AGPAT2 O15120 2/20 0.43
▸ LMNA P02545 2/20 0.42
▸ RAB9A P51151 8/20 0.39
▸ NPC1 O15118 7/20 0.39
▸ MAPT P10636 6/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ CA12 O43570 1/20 0.39
▸ CA1 P00915 1/20 0.39
▸ CA2 P00918 1/20 0.39
▸ CA9 Q16790 1/20 0.39
▸ PABPC1 P11940 1/20 0.39
▸ JAK2 O60674 3/20 0.39
▸ HTT P42858 2/20 0.38
▸ ADORA2A P29274 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.36
▸ GAA P10253 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Barbital SCHEMBL1649531 0.89 RAB9A (0.51) AGPAT2LMNARAB9ANPC1MAPT
Barbital SCHEMBL1649517 0.88 LMNA (0.42) AGPAT2LMNARAB9ANPC1MAPT
Barbital SCHEMBL1650202 0.88 AGPAT2 (0.46) AGPAT2LMNARAB9ANPC1MAPT
Barbital SCHEMBL1650201 0.87 MAPT (0.48) LMNARAB9ANPC1MAPTMEN1
Barbital SCHEMBL1648456 0.80 NPC1 (0.38) AGPAT2LMNARAB9ANPC1MAPT
Barbital SCHEMBL1649164 0.80 RAB9A (0.55) LMNARAB9ANPC1MAPTMEN1
Barbital SCHEMBL1648863 0.79 NFKB1 (0.40) AGPAT2RAB9ANPC1CA12CA1
Barbital SCHEMBL1648828 0.79 MAPT (0.49) AGPAT2LMNARAB9ANPC1MAPT
SCHEMBL2126846 0.78 RAB9A (0.58) AGPAT2LMNARAB9ANPC1MAPT
Barbital SCHEMBL2128368 0.76 LMNA (0.44) LMNARAB9ANPC1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070026078-A1 Pharmaceutical co-crystal compositions TRANSFORM PHARMACEUTICALS, INC. (US) 2007-02-01 — — US claimed
US-7927613-B2 Pharmaceutical co-crystal compositions UNIVERSITY OF SOUTH FLORIDA (US) 2011-04-19 — — US disclosed
US-20100311701-A1 Pharmaceutical Co-Crystal Compositions TRANSFORM PHARMACEUTICALS, INC (US) 2010-12-09 — — US disclosed
US-20070059356-A1 Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen REGENTS OF THE UNIVERSITY OF MICHIGAN, THE 2007-03-15 — — US disclosed
US-20070026078-A1 Pharmaceutical co-crystal compositions TRANSFORM PHARMACEUTICALS, INC. (US) 2007-02-01 — — US disclosed
Send feedback